Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Glycerin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL29623841 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL15061 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL30460570 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL33458 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL1685690 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL1685695 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL1685689 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL31032269 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL8151443 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN | |
| Glycerin SCHEMBL29793596 | 1.00 | LMNA (0.60) | LMNAALDH1A1FFAR3LCKFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 626 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3355853-B1 | ARTIFICIAL SWEAT COMPOSITION | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-3756489-B1 | ELECTRONIC CIGARETTE FILLER AND ELECTRONIC CIGARETTE CARTRIDGE USING SAME | FUTURE TECHNOLOGY CO LTD (JP) | 2024-07-31 | — | — | EP | claimed |
| CN-116706179-A | Preparation method and application of electrolyte of all-vanadium redox flow battery | 江西江钒科技实业有限公司 | 2023-09-05 | — | — | CN | claimed |
| US-11446231-B2 | Oral care compositions and methods for the same | COLGATE-PALMOLIVE COMPANY (US) | 2022-09-20 | — | — | US | claimed |
| US-20220184165-A1 | Novel Compounds and Pharmaceutical Preparations | DICOT AB (SE) | 2022-06-16 | — | — | US | claimed |
| US-11261366-B2 | Barrier pills containing viscoelastic surfactant and methods for using the same | HALLIBURTON ENERGY SERVICES, INC. (US) | 2022-03-01 | — | — | US | claimed |
| US-10828242-B2 | Artificial sweat composition | SYMRISE AG (DE) | 2020-11-10 | — | — | US | claimed |
| US-20190105250-A1 | ARTIFICIAL SWEAT COMPOSITION | SYMRISE AG (DE) | 2019-04-11 | — | — | US | claimed |
| US-9879503-B2 | Methods of treating long-interval and high-contrast permeability subterranean formations with diverting fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2018-01-30 | — | — | US | claimed |
| CN-106317436-A | Ultraviolet prevention and heat insulation glass | 张云德 | 2017-01-11 | — | — | CN | claimed |
| EP-1125497-B1 | Product for virucidal disinfection of the hands | KESLA FORSCHUNG U SERVICE KG (DE) | 2003-06-18 | — | — | EP | claimed |
| EP-1244365-B1 | METHOD FOR PRODUCING AN ACIDIFIED FILTER FOR TOBACCO PRODUCTS AND THE USE THEREOF | REEMTSMA H F & PH (DE) | 2003-05-02 | — | — | EP | claimed |
| CN-1384734-A | Surface-modified microparticle compositions of biologically active substances | RTP PHARMA INC (US) | 2002-12-11 | — | — | CN | claimed |
| US-6391947-B1 | MIXTURE CONTAINING WATER, COLORING AND WATER SOLUBLE POLYMER | CANON KABUSHIKI KAISHA (JP) | 2002-05-21 | — | — | US | claimed |
| EP-0738244-B1 | PROCESS FOR PRODUCING CERAMIC GREEN COMPACTS BY DOUBLE LAYER COMPRESSION | CERAMTEC AG (DE) | 2000-11-08 | — | — | EP | claimed |
| CN-1240346-A | Injectable depot gel composition and method of preparing the composition | ALZA CORP (US) | 2000-01-05 | — | — | CN | claimed |
| US-5667548-A | Process for producing ceramic green compacts by double layer compression | Graule, Thomas (CH) | 1997-09-16 | — | — | US | claimed |
| EP-0383018-B1 | Process for impregnating tobacco smoke filter fibres with polycarboxylic acid or salts thereof | BAT CIGARETTENFAB GMBH (DE) | 1994-01-05 | — | — | EP | claimed |
| EP-0346648-B1 | PROCESS FOR IMPREGNATING THE FIBRES OF A TOBACCO SMOKE FILTER WITH DI- OR POLYCARBOXYLIC ACIDS OR THEIR ANHYDRIDES | British-American Tobacco (Germany) GmbH (DE) | 1993-01-07 | — | — | EP | claimed |
| US-3981798-A | LIQUID EXTRACTION USING CERTAIN ETHERS AND ESTERSMONO-ETHYL OR MONO-METHYL ETHER OF GLYCERINE, GLYCERINE MONO- OR DI-ACETATE | NALCO CHEMICAL COMPANY (US) | 1976-09-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220184165-A1 | Novel Compounds and Pharmaceutical Preparations | PDE8B, PDE3B, PDE4D | LMNA 4654/4885ALDH1A1 2608/4885FFAR3 4299/4885 |
| US-11446231-B2 | Oral care compositions and methods for the same | RPN1, PSMC2, KRTCAP2 | LMNA 1281/4885ALDH1A1 2545/4885FFAR3 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.